Ken Griffin ENLIVEN THERAPEUTICS INC Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024
Number of Shares
100
Previous 3,600 97.22%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
N/A
-573,837 Reduced 24.86%
1,733,977 $0
Q2 2024

Aug 14, 2024
SELL
N/A
-46,589 Reduced 1.98%
2,307,814 $0
Q1 2024

May 15, 2024
SELL
N/A
-40,045 Reduced 1.67%
2,354,403 $0
Q4 2023

Feb 14, 2024
BUY
N/A
42,957 Added 1.83%
2,394,448 $0
Q3 2023

Nov 14, 2023
BUY
N/A
55,281 Added 2.41%
2,351,491 $0
Q1 2023

May 15, 2023
BUY
N/A
2,296,210 New
2,296,210 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email